Google
VANI — VIVANI MEDICAL INC. (Healthcare >> Biotechnology)
VANI FAQ
What is VANI's ROE?
VIVANI MEDICAL INC. reports a Return on Equity (ROE) of -141.93%.
What is VANI's dividend yield?
VIVANI MEDICAL INC. offers a dividend yield of 0.00%.
What is VANI's Deepscope Quality Score?
Deepscope rates VANI's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy VANI?
Deepscope's AI Timing Score for VANI is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does VANI belong to?
VIVANI MEDICAL INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 1.28
Price
-0.02
(-1.54%)
Day Change
|
|
|---|
VANI, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.28 |
| PBV / Sector |
5.87 / 4.48
|
| Earning Per Share | -0.31 |
| PE / Sector |
N/A / 16.68
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
0.25 M
GREAT
|
| Average 1W Daily Value |
0.21 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-04 09:24:06 |
| Symbol | VANI |
| Name | VIVANI MEDICAL INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 86.24 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 112.11 / 8,483.11 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1350 South Loop Road, Alameda, CA, United States, 94502
Phone: 415 506 8462
Website: https://www.vivani.com
Sector: Healthcare >> Biotechnology
Description: Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
